Systemic Scleroderma: Clinical Trials

3 trials for Systemic Scleroderma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 23Completed 3

Follow Systemic Scleroderma: new trials by email Literature Review of Systemic Scleroderma trials Research Report on Systemic Scleroderma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
C-82 Topical Gel, 1%, C-82 Topical Gel, Placebo - Systemic Scleroderma
Phase 1 / Phase 2CompletedPrism Pharma Co., Ltd.172015-06-012017-08-17
Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS - SYSTEMIC SCLERODERMA, ALLOGENEIC MESENCHYMAL STEM CELLS
Phase 1 / Phase 2CompletedAssistance Publique - Hôpitaux de Paris202014-05-062024-05-01
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
fludarabine phosphate, Mycophenolic Acid, tacrolimus - Systemic Scleroderma, Severe Systemic Sclerosis
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center32006-09-012018-06-04

Narrower conditions

Scleroderma, Systemic (3)  ·  Scleroderma, Diffuse (2)

Broader conditions

Connective Tissue Diseases (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)

Interventions

Biopsy (1)  ·  Bone Marrow Transplantation (1)  ·  Flow Cytometry (1)  ·  Mycophenolic Acid (1)  ·  Stem Cell Transplantation (1)  ·  Tacrolimus (1)  ·  Transplantation (1)  ·  Whole-Body Irradiation (1)  ·  fludarabine phosphate (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Fred Hutchinson Cancer Center (1)  ·  Prism Pharma Co., Ltd. (1)

Countries

United States (2)  ·  France (1)

Top investigators

George Georges (1)  ·  Robert Lafyatis, MD (1)

Results publications

PMID 36928395

NIH funding

R01AI041721 (1)